Tom Koenig

Executive Director, Biosimilar Market Access

Boehringer Ingelheim

Tom Koenig is the executive director, biosimilar market access at Boehringer Ingelheim. He is responsible for the commercial development and implementation of market access strategies for biosimilar candidates. Tom has had a diverse background that includes leadership roles in market access, account management, payer marketing and sales management during his 20-plus year career. Previously, Tom served as senior director of payer and market access strategy at Biogen where he was responsible for market access strategies in support of the launch of two new hemophilia therapeutics and Alzheimer’s disease pipeline products.

Asembia

200 Park Avenue, Suite 300 
Florham Park, NJ 07932

973.564.8004

asembia.com

info@asembiasummit.com

SIGN UP FOR SUMMIT UPDATES

Asembia's Specialty Pharmacy Summit is a PRIVATE EVENT. Asembia reserves the right to deny registration and refuse access at our absolute and sole discretion for any reason whatsoever.

Terms & Conditions © 2019 Asembia Specialty Pharmacy Summit, LLC. All rights reserved.

CONNECT WITH US

  • Asembia LinkedIn
  • Asembia Twitter
  • Asembia Instagram
  • Asembia Videos
  • Asembia Photos
SummitLogo_2020_White.png